main-img
Back to Home » October 2019 News » Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS®

Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS®

October 01, 2019

PHILADELPHIA, Oct. 1, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of ADVAIR DISKUS® (Fluticasone Propionate – Salmeterol Xinafoate Powder Inhaler) of...

Source URL: https://www.prnewswire.com:443/news-releases/lannett-enters-into-distribution-agreement-for-generic-advair-diskus-300928052.html
Browse News